Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
BMC Psychiatry|July 6, 2021
Study protocol for a randomised placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (the PAX-BD study)Lumbini Azim, Paul Hindmarch, Georgiana Browne, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 7, 2018
Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definitionDiego Hidalgo-Mazzei, Michael Berk, Andrea Cipriani, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 5, 2021
DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis - A narrative review from the ECNP bipolar disorders networkLars Vedel Kessing, Ana González-Pinto, Andrea Fagiolini, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 16, 2020
Translating big data to better treatment in bipolar disorder - a manifesto for coordinated actionMirko Manchia, Eduard Vieta, Olav B Smeland, et al.
Nature Medicine|August 31, 2023
Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalizationMaxime Taquet, Zuzanna Skorniewska, Adam Hampshire, et al.
BMC Psychiatry|June 3, 2014
Study protocol: The Whitehall II imaging sub-studyNicola Filippini, Enikő Zsoldos, Rita Haapakoski, et al.
The Lancet. Psychiatry|July 2, 2025
Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UKMichael Browning, Philip J Cowen, Ushma Galal, et al.
Brain Communications|January 17, 2024
Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injuryMaxime Taquet, Zuzanna Skorniewska, Henrik Zetterberg, et al.
The Lancet. Psychiatry|August 3, 2024
Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UKMaxime Taquet, Zuzanna Skorniewska, Thomas De Deyn, et al.
Eclinicalmedicine|January 25, 2021
Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital dischargeBetty Raman, Mark Philip Cassar, Elizabeth M Tunnicliffe, et al.
Pageof 17